Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silene Biotech was a Seattle-based biotechnology startup specializing in consumer stem cell banking and personalized stem cell generation. The company enabled individuals to cryogenically preserve their own cells for potential future use in regenerative or personalized therapies. It also partnered with companies developing therapeutics and provided human-relevant cells for early-stage drug development. In September 2019, Silene was acquired by NanoSurface Biomedical to expand capabilities in human stem cell-based platforms for drug discovery[4][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sileno.